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Abstract
Background: Chronic illnesses like obesity, type 2 diabetes (T2D) and cardiovascular diseases, are worldwide major
causes of morbidity and mortality. These pathological conditions involve interactions between environmental,
genetic, and epigenetic factors. Recent advances in nutriepigenomics are contributing to clarify the role of some
nutritional factors, including dietary fatty acids in gene expression regulation. This systematic review assesses
currently available information concerning the role of the different fatty acids on epigenetic mechanisms that affect
the development of chronic diseases or induce protective effects on metabolic alterations.
Methods: A targeted search was conducted in the PubMed/Medline databases using the keywords “fatty acids and
epigenetic”. The data were analyzed according to the PRISMA-P guidelines.
Results: Consumption fatty acids like n-3 PUFA: EPA and DHA, and MUFA: oleic and palmitoleic acid was associated
with an improvement of metabolic alterations. On the other hand, fatty acids that have been associated with the
presence or development of obesity, T2D, pro-inflammatory profile, atherosclerosis and IR were n-6 PUFA, saturated
fatty acids (stearic and palmitic), and trans fatty acids (elaidic), have been also linked with epigenetic changes.
Conclusions: Fatty acids can regulate gene expression by modifying epigenetic mechanisms and consequently
result in positive or negative impacts on metabolic outcomes.
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Introduction
Nutriepigenomics is an emerging scientific area that stud-
ies the relationships between nutrition and the epigenetic.
In recent years, several studies have focused on the de-
scription of different dietary components that can contrib-
ute to modify epigenetic processes and consequently,
modulate gene expression and metabolic responses. These
epigenetic modifications may be associated with the sus-
ceptibility to develop non-communicable chronic diseases
(NCCD), such as obesity, lipid disorders, insulin resistance
(IR), cardiovascular diseases (CVD), type 2 diabetes (T2D),
and some types of cancer [1].
Epigenetics is defined as the study of heritable changes
in DNA and histones without concomitant alterations in
the nucleotide sequence [2, 3]. These modifications can
affect gene expression and the phenotype in response to
environmental stimuli [2, 4]. The main epigenetic mech-
anisms include DNA methylation, histone modifications,
and non-coding RNAs such as microRNAs (miRNAs),
among others [5].
Epigenetic changes are plastic genomic processes that
are influenced by endogenous and exogenous factors,
and these modifications could be potentially propagated
from one generation to the next [6]. Thus, it might be
possible to reprogram epigenetic modifications that are
associated with an increased disease risk through nutri-
tional or lifestyle changes. In this context, a number of
nutritional factors involved in epigenetic modifications
have been reported, including methyl donors, amino
acids, vitamins and minerals, polyphenols, and other
phytochemicals, and fatty acids (FA) [7].
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Regarding FA, some studies have demonstrated the ef-
fects of n-3 and n-6 polyunsaturated acids (PUFA) on
DNA methylation, including specific responses of eicosa-
pentaenoic acid (EPA), docosahexaenoic acid, (DHA),
[8] and arachidonic acid (AA) [9]. However, the mecha-
nisms underlying the effects of different types of FA on
epigenetic landmarks, are still not completely known.
The most extensively studied FA is butyric acid, a short-
chain fatty acid produced in the anaerobic colonic fer-
mentation that can act as an inhibitor of histone deace-
tylases (HDAC) and has been associated with histone
deacetylation [10].
In the last years, the profile of FA intake has dramatic-
ally changed from diets with high monounsaturated
(MUFA) and polyunsaturated fatty acid (PUFA) content,
to a Westernized dietary pattern characterized by a high
content in saturated fatty acids (SFA) and trans fatty
acids (TFA) and poor in n-3 PUFA [11]. This nutritional
transition is associated with the rising prevalence of
NCCD, which have been recently associated with aber-
rant epigenetic changes and are now major cause of
death worldwide [12].
It is well known that obesity, CVD, IR, T2D, cancer
and other NCCD involving multifactorial and genetic in-
teractions [13]. In this context, the study of pathophysio-
logical, genetic and epigenetic processes could help to
design new integral strategies for the prevention and
treatment of these conditions [14]. Therefore, the object-
ive of the present review is to describe the role of dietary
FA in the modulation of epigenetic landmarks in relation
to the development of NCCD, and their ability to reverse
the epigenetic landscape.
Methods
This systematic review has been developed according to
the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses Protocol (PRISMA-P) guidelines
[15]. Literature search was performed using PubMed/
Medline databases and just English papers were consid-
ered. According to PRISMA-P procedures, the key
words “FA and epigenetics” (including SFA, MUFA and
PUFA) and the period of publication “2010–2017” were
used as filters. At this stage, a total of 620 articles were
identified. A flow diagram showing the selection process
is depicted (Fig. 1).
Eligibility criteria
First inclusion criteria were articles analyzing the effects
of FA on epigenetics mechanisms. In this section, 438
articles were removed because do not include interac-
tions between epigenetics and FA. In a second step, arti-
cles not focused on the effect of metabolic alterations
through epigenetic mechanisms in response to FA intake
or supplementation were also excluded (n = 63).
Subsequently, articles showing inconsistent results, did
not fulfill quality criteria or using valproic acid (consid-
ered a drug), were eliminated (n = 71). Lastly, articles
that did not specify the type of FA intervention were
also excluded (n = 17). The final analysis included 31 ar-
ticles; however, seven additional articles obtained from
reference lists were also incorporated in this review (Fig.
1).
Data extraction, data elements
Relevant information from all 38 papers was analyzed
using a standardized data extraction template where two
co-authors were specifically involved. Data about the
type of FA used for treatment, the study model, the
underlying epigenetic mechanism as well as the main re-
sults related to metabolic outcomes, were reported, more
details are shown in Additional file 1.
Quality assessment
Study quality was evaluated according to Jadad scale for
clinical trials and it was considering randomization,
blinding and withdrawals and dropouts. The selection
criteria of the articles had to meet at least 3 criteria to
be included. In this review, two authors evaluated the
quality of papers and to resolve some disagreements all
the author make a consensus procedure to define if the
article full fill the criteria for be included in the system-
atic review.
Data analysis
The acquired information was organized based on the
type of FA and experimental model analyzed. The data
were sorted according to fatty acids subtypes; firstly, un-
saturated fatty acids were described (PUFA: n-3, n-6 and
MUFA: oleic) (Table 1). Then, saturated and trans fatty
acids were sorted in a second category (Table 2). Butyr-
ate was independently analyzed from other FA because
it is a product of anaerobic colon fermentation (Table 3).
Finally, articles including more than one type of FA were




N-3 PUFA In the last years, many investigations have
focused on the effects of n-3 PUFA in the prevention
and treatment of different metabolic alterations. Thus,
Tremblay and collaborators investigated the effect of n-3
PUFA supplementation in overweight and obese subjects
on epigenetic modifications [16]. They found that after a
6-month supplementation 308 CpG sites (231 genes)
had different methylation pattern, of which 286 CpG
sites were hypermethylated representing 93% of the
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changes after the supplementation and 22 were hypo-
methylated (just 7%), using ingenuity pathway analysis sys-
tem it was reported these epigenetic changes were related
to pathways associated with inflammatory and immune
responses, lipid metabolism, T2D, and cardiovascular
signaling [16].
Another study in obese subjects under an energy-
restricted diet supplemented with n-3 PUFA-rich fish oil
conducted by do Amaral and collaborators found that
the methylation levels of PDK4 (Pyruvate Dehydrogenase
Kinase 4) CpG sites − 222 and − 50 and FADS1 CpG −
25 − 22 − 20 were increased in the group supplemented
with fish oil. Furthermore, n-3 PUFA supplementation
was accompanied by improved weight loss, which was
associated with changes in the methylation pattern of
one specific CpG site in CD36, a gene that encodes a
membrane glycoprotein that plays a relevant role in lipid
metabolism and may be implicated in obesity-related
complications like glucose intolerance and T2D [19].
On the other hand, Aslibekyan et al. investigated the
effect of n-3 PUFA intake in a population of Yupik na-
tives, considering that this population had a higher
intake of fish-derived n-3 PUFA [17]. For this study, the
population was categorized in higher and lower deciles
of a nitrogen stable isotope ratio (δ15N), which is a bio-
marker of n-3 PUFA intake and thus, n-3 PUFA plasma
content. The authors found 27 differentially methylated
CpG sites at biologically relevant regions that reached
epigenome-wide significance and highlighted that DNA
methylation may reduce FAS (apoptosis antigen 1) ex-
pression and, consequently, regulate lipid metabolism
through the apoptotic pathway. Also, the methylation
pattern of AHRR (Aryl-Hydrocarbon Receptor Repres-
sor), a gene that is involved in oxidative stress, was af-
fected by the n-3 PUFA intake, which was accompanied
by a positive impact on glucose tolerance and insulin
sensitivity [17].
In addition, Arpón et al. studied the effect of Mediter-
ranean Diet (MedDiet) complemented with extra virgin
olive oil (EVOO) or nuts on DNA methylation within
PREDIMED (PREvención con DIeta MEDiterránea)
study. They compared the two diets MedDiet + EVOO
and MedDiet + nuts with a low-fat control group during
five-year follow-up and found that MedDiet + nuts
Fig. 1 PRISMA flow diagram. Summarizing the selection of papers included in this review (using the term “FA and epigenetics”). Human studies,
animal models, and in vitro experiments, were included. FA: Fatty acids
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favors a hypermethylation of cg01081346 in CPT1B/
CHKB-CPT1B genes (Carnitine palmitoyltransferase 1B/
Choline kinase-like, Carnitine palmitoyltransferase 1B)
and MedDiet + EVOO induce hypomethylation in
cg17071192 in GNAS/GNASAS genes GNAS/GNASAS
(Guanine Nucleotide Binding Protein, G Protein), how-
ever both diets were associated with intermediate metab-
olism as well as improve genes involved in diabetes and
inflammation pathways [18].
Transgenerational studies Several investigations have
reported the effects of n-3 PUFA supplementation
(DHA) in the maternal diet on epigenetic changes in the
offspring [21, 22]. Thus, Lee and collaborators demon-
strated that DHA supplementation in pregnant women
demonstrated higher methylation levels of IGF2/H19 in
their offspring versus control group, a gene that is cru-
cial for the correct fetal growth, development, and me-
tabolism of the infants and this effect was dependent on
the maternal BMI before pregnancy. Furthermore, IGF2/
H19 DMR methylation changes have also been associ-
ated with paternal obesity or the risk of overweight, dia-
betes or some types of cancer in early life [21].
On the other hand, Van Dijk et al. found in a large
randomized controlled trial that DHA supplementation
during pregnancy did not significantly affect the global
methylation pattern, although they identified 21 differen-
tially methylated regions (DMRs) at birth (this difference
was sex-dependent) in genes implicated in diverse func-
tions including lipid exchange between membranes
(ESYT3), appetite regulation (CCK), and immune func-
tion (RAET1L and LTB) among others [22].
N-6 PUFA A trial by Hermsdorff et al. showed that AA
intake (an n-6 PUFA) was related with higher values of
truncal fat, BMI, and waist circumference in women [20].
Moreover, they found a negative correlation between the
methylation of TNF and the levels of this proinflammatory
cytokine. In particular, the hypermethylation of two CpGs
of this gene (+ 207 and + 317pb) was associated with the
under expression of the gene, and the result of a linear re-
gression model suggest this methylation levels of TNFα
promoter were associated with n-6 PUFA intake, suggest-
ing a complex nutriepigenomic interaction that could ex-
acerbate the proinflammatory state [20].
Animal models
N-3 PUFA In a study to explore whether n-3 PUFA af-
fects DNA methylation levels in colorectal cancer, rats
were fed with n-3 PUFA during tumor induction [23].
The main results showed that the tumor incidence in
rats fed the n-3 PUFA-enriched diet was lower than in
the non-treated group, demonstrating that the anti-
tumorigenic effect of n-3 PUFA was mediated by an in-
crease of DNA methylation [23]. On the other hand,
Shen et al. observed that n-3 PUFA could modulate his-
tone modifications by inhibiting enzymes that catalyze
or alter the availability of substrates that are required for
enzymatic reactions. A significantly lower activity of
DNMT1 (DNA methyltransferase 1) and MBD2 (Me-
thyl-CpG-binding domain protein 2) enzymes was ob-
served in mice fed the n-3 PUFA-enriched diet. This
outcome was accompanied by an increase in H3 acetyl-
ation, lower binding levels of HDAC1, HDAC2, HDAC6
and higher levels of methyl-H3K4 and -H3K9. Hence,
the authors concluded that the regulation of leptin ex-
pression by n-3 PUFAs is mediated by epigenetic factors,
such as MBD2 and histone modifications. Furthermore,
n-3 PUFA supplementation in high fat-fed rodents de-
crease leptin mRNA expression, ameliorate leptin resist-
ance, and decreased the differentiation and proliferation
of adipocytes and their storage capacity [24].
Transgenerational studies A genome-wide methylation
study was conducted in pigs to determine the effect of
prenatal and postnatal n-3 PUFA supplementation
(throughout gestation, lactation, and post-weaning pe-
riods) on the methylation pattern of the offspring [20].
Different methylation patterns were observed when
comparing the supplemented and non-supplemented
groups in chromosome 4, finding a hypomethylated
DMR in supplemented groups; conversely, hypermethy-
lation was detected in two intergenic regions of chromo-
somes 4 and 12. The authors concluded that the genes
differentially methylated in the offspring were mainly
involved in pathways that were improved by the n-3
PUFA supplementation, such as apoptosis, endoplasmic
reticulum stress, glucose and insulin homeostasis, im-
mune function, inflammatory profile, glucose uptake,
lipid metabolism, and oxidative stress [25]. On the other
hand, another study reported that EPA was able to in-
hibit the expression of lipogenic genes while up-
regulating genes involved in fatty acid oxidation [53].
In conclusion, the effects of PUFA depend upon the
subtype of FA, (n-6 or n-3; AA and EPA-DHA, respect-
ively), the doses, the sources, and the way of administra-
tion (in foods or as nutraceutical). In this sense, more
studies are needed in humans and animal models, to un-
cover the epigenetic effects of PUFA in relation to their
beneficial role in NCCD.
In vitro models
N-6 PUFA Silva-Martínez et al. studied the effect of AA
on global DNA methylation and gene expression in cul-
tured human THP-1 monocytes. The cell stimulation
was for 24 h using different concentrations of AA (1, 10,
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or 100 μM). The results showed that AA induced a
dose-dependent DNA hypermethylation peak at the 100
mM dose and the AA stimulation could alter the methy-
lation profile in a similar way that was reported with pal-
mitic acid (saturated acid that was related with aberrant
epigenetic changes). This methylation profile was associ-
ated with the alteration of pathways involved in meta-
bolic diseases like atherosclerosis, T2D, obesity, the
proinflammatory profiles, and some types of cancer [26].
Another research group employed human umbilical
vein endothelial cells (HUVECs) and endothelial progen-
itors (EPCs) to study the effect of AA on DNA methyla-
tion and the expression of genes related to angiogenesis
as a mechanism involved in the carcinogenesis process
[9]. After the stimulation with AA (3 μM) for 24 h, the
expression of 18 proangiogenic genes was affected. The
authors concluded that the beneficial effect of AA on
carcinogenesis may be due, at least in part, to changes in
the expression of angiogenic genes, which may be medi-
ated by changes in DNA methylation [9].
MUFA In addition to AA, Silva-Martínez et al. also eval-
uated the impact of oleic acid (OA) on cultured human
THP-1 monocytes [26]. This study demonstrated that
OA had an opposite effect than AA, inducing a global
hypomethylation and consequently an expression pat-
tern that were related with an improvement of the in-
flammation profile [26].
As previously described for PUFA, the epigenetic ef-
fects of MUFA depended on the subtype of FA and the
doses. For example, OA, whose principal sources are
vegetable, oils like olive oil, can ameliorate processes re-
lated to atherosclerosis, inflammation, T2D and obesity
through epigenetic modifications [26].
By other hand, palmitoleic acid is an n-7 MUFA that
is biosynthesized from palmitic acid (SFA) whose princi-
pal sources are of animal origin and dairy products [54].
Thus, FA can also alter the epigenome, affecting genes
associated with prevention of insulin resistance and dia-
betes and improved lipid and glucose metabolism [55].
Saturated and trans fatty acids
Human studies
Trans FA Dietary trans-fatty acids (TFA) are associated
with an increased risk of metabolic diseases. Some of
these effects can be mediated by epigenetic mechanisms.
For example, a study in humans associated industrial
TFA consumption with HDL-carried miRNA concentra-
tions and plasmatic HDL-c levels [28]. The diet rich in
industrial TFA altered the concentrations of 5 miRNA
in purified HDL and also contributed to 13 HDL-carried
miRNA to the plasmatic miRNA pool. These miRNAs
modified through the TFA- enriched diet were
associated with lipid metabolism and extracellular matrix
receptor interaction, suggesting an important role of
miRNAs in plasma lipid metabolism regulation [28].
Animal models
Trans FA
Transgenerational Flores-Sierra et al. studied the ef-
fects of elaidic acid (EA) supplementation during either
pregnancy or lactation in C57BL/6 mice. In both cases,
EA supplementation was observed to induce global
DNA methylation in the adipose tissue of the offspring
3 months after birth, and it was associated with weight
gain and adipose tissue accumulation [27].
In vitro models
Trans FA The study by Flores-Sierra et al. evaluated the
effect of TFA elaidic acid (EA; tC18:1) on global DNA
methylation and gene transcription in cultured human
THP-1 monocytes. They found a biphasic dose-
dependent response and global hypermethylation was
described in the 1–50 μM concentration range, whereas
global hypomethylation was observed in concentrations
up to 200 μM. The main results showed that EA affected
the expression of genes related to pro-inflammatory and
adipogenic profiles, but it also affected DNA methyla-
tion, suggesting that EA can target gene-body or inter-
genic regulatory elements [27].
Saturated FA Investigations carried out by Kumar and
et al. studied models of IR in human-urine derived
podocyte-like epithelial cells (HUPECs) and in male
Sprague-Dawley rats, which were fed a high-fat diet.
HUPECs were stimulated with 750 μM palmitate, a con-
centration that is two to three times higher than the
palmitate level in normal non-esterified fatty acids
(NEFA) [29]. The results showed that an excess of circu-
lating palmitate generated a FA–induced metabolic
memory possibly by altering the levels of H3K36me2
and H3K27me3 on the FOXO1 promoter region, in-
creasing its activity. In conclusion, palmitate favored IR-
induced gluconeogenesis and hyperglycemia, and this ef-
fect persisted even after normalization of lipid levels
both in vitro and in vivo, representing cellular metabolic
memory [29].
In this context, other researchers have analyzed the ef-
fect of palmitate on genome-wide mRNA expression and
DNA methylation, in human pancreatic islets in vitro
[30]. They reported an increase in the average global
DNA methylation in different gene regions including
TSS1500, 5′UTR, gene body, 3′UTR and intergenic re-
gions, and a small decrease in global methylation in
TSS200 and the 1st exon. Palmitate altered DNA
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methylation levels in 290 genes, 73 of which were related
to BMI. The expression of 1860 genes were also affected
by palmitate, including genes involved in T2D (TCF7L2,
GLIS3, HNF1B, and SLC30A8), and genes associated
with glycolysis and gluconeogenesis, FA metabolism dys-
regulation, and one carbon pool by folate [30].
On the other hand, Ishikawa et al. differed from the
other reports, finding that palmitate did not affect DNA
methylation levels of the Ins1 gene promoter in normal
or high glucose conditions, which could be due to differ-
ences in the doses and genes considered in both studies
[31].
Furthermore, Maples et al. found that oleate-palmitate
(250 μM oleate-palmitate 1:1 ratio) favored DNA methy-
lation in relation to PPAR δ expression in human skel-
etal muscle cells (HSkMC) from lean and severely obese
women. However, this increase in DNA methylation was
lower in HSkMc from obese women, suggesting that
obesity can activate transcriptional regulators of FA oxi-
dation in response to FA exposure. In conclusion, the
occurrence of different epigenetic alterations in HSkMC
after lipid stimulation suggests that a specific epigenetic
programming may occur in obese subjects as a response
to their own environmental conditions [32].
The effects of stearate and palmitate on the methyla-
tion of Pparg promoter were investigated in Raw264.7
murine macrophages. The incubation with these SFA in-
creased IL-4 levels and the methylation of Pparg, sug-
gesting that Pparg hypermethylation could mediate the
proinflammatory effects of these SFA and contribute to
IR in obesity [33].
The harmful effects of some SFA are well known. For
example, palmitic and stearic FA have been involved in
pro-inflammatory and metabolic alterations. Different
investigations have demonstrated their contribution to
the modulation of DNA methylation and histone acetyl-
ation in relation to their effects on IR, obesity, hypergly-
cemia, T2D, lipotoxicity, dysregulation of lipid
metabolism, and abnormal lipid accumulation [29–33].
In the last years, the increased consumption of processed
and industrialized food, with higher amounts of SFA and
TFA, has been associated with inflammation, adipogene-
sis, abnormal accumulation of adipose tissue, alterations
in lipid metabolism, and carcinogenesis processes, which
could be mediated by changes in DNA methylation, co-
valent histone modifications, and some miRNAs.
Short-chain fatty acids Short-chain fatty acids (SCFA)
are products of microbial fermentation that can be
absorbed in the large intestine [56]. These SCFA can
modify epigenetic landmarks (i.e., histone acetylation)
and modulate the expression of genes related to path-
ways associated with cancer, lipid metabolism, glucose
homeostasis, and insulin sensitivity, among others. For
example, sodium butyrate (NaB) has been demonstrated
to inhibit HDAC activity [57–59].
Animal models
Sodium butyrate (NaB) Research by Khan et al. studied
the effect of NaB supplementation in juvenile diabetic
rats, demonstrating a role for NaB as an HDAC inhibitor
associated with a decrease in glucose and Hba1c, favor-
ing insulin sensitivity and reducing the risk of develop-
ing diabetes [34].
Protective anti-obesity and anti-diabetic effects of NaB
have been also reported in a model of C57BL/6 J mice
exposed to a high-fat diet [35]. NaB prevented the in-
crease of body weight and adiposity and improved insu-
lin sensitivity, increasing the percentage of type-1 fibers
and improving acylcarnitine profiles in muscle [35]. In
this context, Mátis et al. also found in chickens that NaB
improved body weight and favored cell function regula-
tion, which was mediated by epigenetic changes, such as
histone hyperacetylation [36].
Transgenerational In a transgenerational study, Huang
et al. demonstrated that an unbalanced maternal diet
was determinant in the development of IR and obesity in
the offspring. Moreover, they analyzed the effect of ma-
ternal butyrate supplementation on insulin sensitivity
and lipid metabolism in the skeletal muscle of the off-
spring. The rats received butyrate diet (1% NaB) during
gestation and lactation for 60 days. The offspring of
dams that were supplemented with NaB had impaired
glucose tolerance and a higher HOMA index (insulin re-
sistance), which was associated with an overexpression
of lipogenic genes. This was accompanied by an increase
in histone H3 (Lys9) and H3 (Lys27) acetylation in rela-
tion to lipogenic genes in the skeletal muscle of the adult
offspring. The authors concluded that, in this model, bu-
tyrate impaired lipid metabolism and insulin sensitivity
in the offspring [37]. This negative effect of butyrate was
inconsistent with other investigators, suggesting that
dose and duration might be important, and indicating
that more studies are necessary to elucidate the role of
NaB and other SCFA in the prevention or treatment of
chronic diseases.
In vitro models
Chinese hamster ovary (CHO) cells were used to analyze
the effect of NaB on the transcriptome and epigenome.
In this study, NaB induced hypomethylation in genes be-
longing to pathways associated with the cell cycle, sig-
naling and apoptosis, whereas hypermethylation was
observed in genes implicated in protein transport and
RNA processing. On the other hand, genes related to
protein biosynthesis, the differentiation process and
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RNA metabolism, were both hyper and hypomethylated.
Besides, authors hypothesized that the affected gene re-
gions presented regulatory regions closely linked with
the cellular response to butyrate stimulation [38].
Another study performed in bovine cells analyzed the
effect of NaB supplementation on histone modifications.
The main findings of the investigation were that the in-
hibition of HDAC caused by NaB promoted hyperacety-
lation of histones and modified the expression of genes
associated with cell growth, proliferation, energy metab-
olism, cell cycle, apoptosis, and differentiation [39].
Likewise, another study found that both, butyrate and
propionate were able to increase histone acetylation in
HELA and HEK293 epithelial cells, and enhance NF-κB
activation (in response to TNF-α) by means of the in-
duction of toll-like receptors (TLRs) These SCFA had an
effect on the proinflammatory response, cell prolifera-
tion and differentiation, redirection of innate immune
response, and cytokine/chemokine expression [40].
Paskova et al. demonstrated that NaB was able to
modify the expression of androgen receptors in prostate
cancer cells through an increase of H4 (Lys8) and H4
(Lys12) acetylation, favoring the suppression of tumor
growth. However, this effect was minimal in normal
cells, suggesting a protective role of NaB in the develop-
ment of prostate cancer mediated by epigenetic modifi-
cations [41].
Consistent with this finding, other authors have re-
ported protective effects of NaB in human gastric cancer
cells, inducing demethylation and histone modifications
at the promoter region of SFRP1/2, and restoring SFRP
(Secreted Frizzled-Related Protein) expression in human
gastric cancer cells. The authors proposed that NaB in-
duced apoptosis, favored complex formation, promoted
caspase activation, and blocked the potential of cancer
cells [42].
Finally, an in vitro study combining 5 mM NaB plus
50 μM DHA, evaluated histone modification and DNA
methylation in genes involved in apoptosis. It was dem-
onstrated that this combination had a hypomethylation
effect on proapoptotic genes (Bcl2l11, Cideb, Dapk1,
Ltbr, and Tnfrsf25) and an increase in global H4 histone
acetylation in cells treated with NaB combined with
DHA; this induction of apoptosis had an anticancer ef-
fect [44].
Other authors studied the effects of NaB on histone
modifications and its consequence on G1-specific cell
cycle regulators in vascular smooth muscle cells
(VSMC), trying to explain the interaction between chro-
matin remodeling and the antiproliferative action of bu-
tyrate. In this model, NaB acted as an HDAC inhibitor
and caused a reorganization of chromatin, affecting the
expression of negative and positive cell cycle regulators
and arresting VSMC proliferation. Hence, NaB was
considered a possible therapeutic agent against athero-
sclerosis [43].
The metabolic effects of butyrate are controversial be-
cause some studies have reported positive outcomes,
such as a reduction in plasma glucose levels and HBA1c,
and an improvement in insulin sensitivity and glucose
homeostasis, preventing the increase of body weight and
adiposity and inducing proapoptotic genes related to
cancer. On the other hand, other studies have described
negative effects of butyric acid, including IR, increased
risk of T2D, lipid accumulation and a pro-inflammatory
profile. Hence, more studies are needed to elucidate the
metabolic effects of SCFA and the underlying epigenetic
mechanisms, such as HDAC inhibition, in order to clar-
ify their role as therapeutic tools against metabolic alter-
ations and chronic diseases.
Comparison of different types of fatty acids
Human studies
In order to analyze the effects of excessive palmitic acid
and n-6 PUFA intake, subjects were instructed to con-
tinue with their habitual diet just with the addition of an
extra high calorie (750-kcal) muffin rich in either palmitic
acid (n = 17) or n-6 PUFA-rich sunflower oil (n = 14). An
adipose tissue biopsy was obtained before and after the
intervention period (7 weeks). In particular, SFA overfeed-
ing increased the mean methylation of 125 genes and
PUFA overfeeding changed the mean methylation of 1797
genes, only 47 genes overlapped between the two diets,
which ones were related to adipose tissue accumulation,
obesity, FA uptake, transport, and lipid metabolism insulin
resistance and inflammation pathways. These results sug-
gest that DNA methylation may be involved in the indi-
vidual response to FA overfeeding [45].
Voisini et al. studied the impact of different ratios of
PUFA, MUFA and SFA in 91 Greek preadolescents (<
10 years). They analyzed the effects of low PUFA:SFA ra-
tio, low MUFA:SFA and low MUFA+PUFA:SFA ratios
on genome-wide DNA methylation. The genes altered in
the lower PUFA:SFA ratio were associated with adipo-
genesis, gene regulation by PPARα, regulation of energy
intake, the inflammatory process and obesity. The low
MUFA+PUFA:SFA ratio was related to pathways linked to
NF-kB (inflammation process). These results suggest that
different types of FA have different effects on the epige-
nome, leading to different physiological responses [46].
On the other hand, Lind et al. designed a study
encompassing 133 (9 month-old infants) that were sup-
plemented with a teaspoon of fish oil (1.5 g/day n-3, 400
mg DHA and 1100 mg EPA) or sunflower oil (3.8 g/day)
during a 9month period. They analyzed global DNA
methylation and did not find statistical differences be-
tween groups; however, they reported that 43 CpG had a
10% difference or more in the absolute methylation level
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between groups, demonstrating differential effects of
both FA. In the PUFA group, they found a higher
amount of n-3, EPA and DHA, but lower levels of n-6
and AA in red blood cells (RBC), which was associated
with an improvement of arterial pressure and a tendency
of lower IL-6 levels [47].
Another study including two different human cohorts,
lactating infants, and adult men, attempted to assess if
there was an association between DNA methylation and
different types of FA, in both fasting and the postpran-
dial state. In the postprandial state, the participants re-
ceived a representative meal of the western diet
(hamburger, fries and coke) and blood was taken after
the meal consumption and every 2 h until 6 pm. In the
fasting day, volunteers were maintained in the fasted
state from 10 am until 6 pm and blood was taken every
2 h. Furthermore, the subjects were separated according
to BMI in normal-weight, overweight and obese. Results
evidenced a different methylation pattern depending on
the BMI and the fasting/postprandial state. The study
found that DNA methylation and histone deacetylation
mediated by PUFA were related to a cardioprotective
and normal-weight status, in contrast to epigenetic land-
marks modulated by MUFA (palmitoleic acid) and SFA
(palmitic acid) that were associated with pathways impli-
cated in obesity, dysregulation of lipid metabolism, and
glucose misbalance [48].
Animal and in vitro models
A study in 34 rats and 3 T3-L1 cells compared the ad-
ministration of different types of FA: sunflower oil rich
in linoleic acid as PUFA, olive oil rich in oleic acid as
MUFA, and coconut oil rich in palmitic acid as SFA. In
rats, DNA methylation of the Tnf promoter was analyzed
in the visceral adipose tissue. While both linoleic acid
(PUFA) and oleic acid (MUFA) did not change Tnf
methylation levels, palmitic acid increased Tnf methyla-
tion and was associated with inflammation, adiposity,
and obesity. The study also concluded that FA may
regulate adipocyte TNF-α levels through changes in the
methylation levels of the Tnf promoter [49].
Moreover, Monastero et al. analyzed the dietary FA-
mediated epigenetic regulation induced by the Vascular
Endothelial Growth Factor B (VEGF-B) in adipose tissue
of rats and in 3 T3-L1 cell lines [50]. Rats fed with coco-
nut oil presented higher levels of VEGF-B expression
and levels of protein, which was associated with the
methylation levels of the promoter. Rats fed sunflower
oil showed the lowest levels of VEGF-B while higher
VEGF-B levels were associated with IR and T2D, as well
as an impaired lipid metabolism [50].
Transgenerational A trasgenerational trial was designed
by Hoilea et al. to determine the effect of maternal FA
consumption on the PUFA status and the epigenetic
regulation of fatty acid desaturase 2 (Fads2) involved in
PUFA synthesis. The dams received two different FA-
rich foods, butter (rich in SFA) or fish oil (rich in n-3
PUFA) and afterwards, the offspring were evaluated.
They found a negative correlation between Fads2 ex-
pression and the promoter methylation levels. The
methylation level of Fads2 was higher in the fish-oil
group that in the butter group, which was related to a
higher accumulation of fat in the liver and a dysregula-
tion of the vascular tone in the butter group. In conclu-
sion, the type of FA affected the regulation of the PUFA
synthesis through epigenetic mechanisms [51].
The type of FA can also affect other epigenetic mecha-
nisms, such as the expression of miRNAs, which can
modulate the expression of different genes [60]. A study
in which pregnant rats were fed soybean oil, olive oil,
fish oil, linseed oil, or palm oil diets from conception to
day 12 of gestation, the aim was to analyze miRNA ex-
pression in adipose tissue and liver of dams and their
offspring. The adipose tissue mass was lower in the fish
oil and linseed oil groups compared with other groups.
Some hepatic miRNAs, such as miR-192–5p, miR-10b-
5p, miR- 377–3p, miR-215, miR-21–5p and mir-26b- 5p,
were downregulated by fish oil compared with olive oil
and palm oil diets. These miRNAs are involved in insu-
lin homeostasis and glucose metabolism. This study con-
cluded that the maternal intake of diverse types of FA
during pregnancy can modulate miRNA expression in
both maternal and offspring tissues, relating to epigen-
etic mechanisms and phenotypic outcomes in the adult
offspring [52]. Other studies found that a high-fat diet in
pregnancy and lactation modulated hepatic miRNAs in
the offspring [61, 62]. Hence, it is necessary to design
more studies to clarify the role of FA in the modulation
of miRNA expression and its association with metabolic
alterations.
Conclusions
Over the last years, a growing number of investigations
have been focused on the protective/beneficial effects of
different FA, including n-3 PUFA and SCFA, in NCCD.
The most consistent literature shows that some of these
effects could be mediated by epigenetic mechanisms
which play a role in the regulation of gene expression. In
addition to n-3 PUFA and SCFA, other FA types, such
as n-6 PUFA, MUFA, SFA, and TFA may also alter epi-
genetic mechanisms, and their effects are still under re-
search. The results show that different types of FA have
a different effect on the epigenome, mainly on DNA
methylation; however, it is necessary to perform more
studies focused on other epigenetic mechanisms, such as
histone modifications and miRNAs and their subsequent
effects on the regulation of gene expression.
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The existing results confirm that FA can influence
DNA methylation (hyper or hypomethylation) as well as
acetylation or deacetylation of histones, and miRNAs as-
sociated with the repression, or activation of genes. For
example, n-3 PUFA (i.e., EPA-DHA), and MUFA (i.e.,
OA, palmitoleic) have been related to the prevention of
metabolic alterations (lipid metabolism disturbances, in-
flammation, and IR) or chronic diseases (obesity, T2D,
non-alcoholic fatty liver disease, cardiovascular risk and
some types of cancer). On the other hand, n-6 PUFA,
such as AA, SFA (stearic and palmitic), and TFA (elaidic
acid), have been associated with the presence or devel-
opment of obesity, T2D, inflammatory profile, athero-
sclerosis, hyperglycemia, IR, lipid alterations, lipotoxicity,
dysregulation of lipid metabolism, and abnormal lipid
accumulation (Fig. 2).
Concerning the effects of n-3 PUFA on the DNA methyla-
tion status, a possible mechanism that has been proposed is
that n-3 PUFA can promote the conversion from C to 5mC
conducted by DNA methyltransferases (DNMTs) by enhan-
cing the expression of DNMTs and consequently influence
DNA methylation [20]. Furthermore, a potential interaction
between n-3 PUFA and MeCP2 (methyl CpG binding pro-
tein 2) has been proposed, mainly in promoter regions, and
consequently could be associated with the regulation of gene
expression [50]. Another possible mechanism by which n-3
PUFAs can affect methylation is that these FA are natural li-
gands of some transcriptional factors, such as PPARγ [51].
In this context, it has been reported that interactions be-
tween PPARγ and fatty acids result in a decrease in cytokine
expression [52], and in murine models, Pparg expression is
modulated by DNA methylation in its promoter region [61].
However, more studies are needed to elucidate the role of
FA in the regulation of epigenetic mechanisms in the con-
text of metabolic alterations and chronic diseases. Regarding
the other types of FA, a specific mechanism in which they
could alter epigenetic landmarks, has not been described.
The intake and supplementation of different types of
FA has demonstrated to have an effect on transgenera-
tional epigenetic mechanisms (being DNA methylation
the most studied). These effects are implicated in the
pathogenic or protective role of FA and can be modu-
lated during pregnancy and lactation, suggesting that
they could be interesting therapeutic targets.
Fig. 2 Summary of the main metabolic effects of fatty acids that can be mediated by epigenetic mechanisms. PUFA: Polyunstaturated fatty acids,
MUFA: Monounsaturated fatty acids, SFA: Saturated fatty acids, SCFA: Short chain fatty acids, EPA: Eicosapentanoic acid, DHA: Docosahexanoic
acid, AA: Arachidonic acid, NCCD: Non-comunicable cronic disease, miRNAS: Non-coding microRNAs, IR: Insulin Resitance
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In this term the role of nutraceuticals as a potent ef-
fect on lipids regulation should be considered, and more
investigations are necessary to elucidate the role of
nutraceuticals depending of the individual genetic vari-
ability [63], and their possible effect on epigenetic modi-
fications for finally encourage the management of
metabolic diseases as an integrative treatment.
SCFA are especially interesting because they take part
of a diet-microbiota-epigenetics axis. For example, bu-
tyrate is a potent non-competitive HDAC inhibitor that
is implicated in the regulation of gene expression. How-
ever, more studies are necessary to understand the regu-
lation of specific genes and consequently their metabolic
effects, as well as to consider the integrative effect of
other components like gut microbiota, because butyrate
is mainly produced by gut microbes, so the interaction
will be very important to understand the complete out-
come [64].
The epigenetic and metabolic effects of the different
types of FA depend on the dose and the model, but
many examples demonstrate that they can modulate the
epigenome. Nevertheless, more studies are necessary to
clarify the specific genes and pathways that are affected
by FA through epigenetic mechanisms and consider
other nutritional components that have an effect on epi-
genetic landmarks, such as methyl donors (vitamin B12,
folate, choline, betaine, methionine, serine, glycine, and
histidine), vitamins (retinol, tocopherols, and ascorbate),
and polyphenols (epigallocatechin 3-gallate, genistein,
curcumin, resveratrol, and sulforaphane, among others).
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